NATIONAL ACTION PLAN ON ANTIMICROBIAL RESISTANCE (NAP-AMR) 2024–2028

What Is This Policy?

The NAP-AMR 2024–2028 is Nigeria’s strategic roadmap to combat antimicrobial resistance (AMR). It integrates surveillance, stewardship, infection prevention, and public awareness across human health, veterinary medicine, agriculture, and the environment.

Who Does It Target?

The plan is directed at healthcare providers, veterinarians, farmers, pharmaceutical industries, and environmental regulators. It also targets communities and the general public, emphasizing responsible use of antibiotics. Development partners (WHO, FAO, OIE, UNEP) and donors are key stakeholders, as AMR is a global health security issue.

What Does It Aim to Achieve?

The central objective is to reduce the burden of drug-resistant infections in Nigeria. It seeks to strengthen surveillance systems, promote rational use of antimicrobials, and improve infection prevention and control. The plan also aims to foster research, innovation, and public awareness, ensuring Nigeria contributes to global AMR containment.

Key Features

• One Health approach: Integration of human, animal, and environmental health. • Surveillance systems: Strengthening labs and data reporting. • Antimicrobial stewardship: Promoting rational use in hospitals and farms. • Infection prevention and control (IPC): Expanding hygiene and sanitation programs. • Public awareness campaigns: Educating citizens on responsible antibiotic use. • Research and innovation: Supporting new diagnostics, vaccines, and alternatives

Current Status

Active and being implemented. The National Action Plan on Antimicrobial Resistance (NAP-AMR) is being implemented under the One Health framework by the Federal Ministry of Health and partner agencies.

Legal Framework

The NAP-AMR operates under Nigeria's national health and environmental policies, integrated with international guidelines from WHO, FAO, OIE, and UNEP as key stakeholders.